Page 1 | Search Results | Blood | American Society of Hematology

1-16 of 16

Sort by

Sort Order Select

Journal Articles

Combination of a Novel HDAC 6 Inhibitor ACY-241 with Anti-PD-L1 Antibody Enhances Anti-Tumor Immunity and Cytotoxicity in Multiple Myeloma

Arghya Ray, PhD, Deepika Sharma Das, PhD, Yan Song, PhD, Teru Hideshima, MD PhD, Dharminder Chauhan, PhD, Kenneth C Anderson, MD

Blood (2016) 128 (22): 382.

https://doi.org/10.1182/blood.V128.22.382.382

Published: 2016

Journal Articles

Deubiquitylating Enzyme USP1 As Therapeutic Target in Multiple Myeloma

Deepika Sharma Das, PhD, Yan Song, PhD, Arghya Ray, PhD, Mehmet K. Samur, PhD, Nikhil C. Munshi, MD, Dharminder Chauhan, PhD, Kenneth C. Anderson, MD

Blood (2016) 128 (22): 3290.

https://doi.org/10.1182/blood.V128.22.3290.3290

Published: 2016

Journal Articles

SL-401, a Novel IL-3Rα/CD123-Directed Agent Targets Stem-like Cells in Multiple Myeloma

Arghya Ray, PhD, Yan Song, PhD, Deepika Sharma Das, PhD, Vincent Macri, MA, Janice Chen, PhD, Claudia Paba-Praba, Paul G. Richardson, MD, Christopher L. Brooks, PhD, Dharminder Chauhan, PhD, Kenneth C. Anderson, MD

Blood (2016) 128 (22): 4463.

https://doi.org/10.1182/blood.V128.22.4463.4463

Published: 2016

Journal Articles

Deubiquitylating Enzyme Rpn11/POH1/PSMD14 As Therapeutic Target in Multiple Myeloma

Yan Song, PhD, Arghya Ray, PhD, Deepika Sharma Das, PhD, Mehmet K. Samur, PhD, Ruben D. Carrasco, MD PhD, Nikhil C. Munshi, MD, Dharminder Chauhan, PhD, Kenneth C. Anderson, MD

Blood (2016) 128 (22): 4469.

https://doi.org/10.1182/blood.V128.22.4469.4469

Published: 2016

Journal Articles

A Novel Agent SL-401 Triggers Anti-Myeloma Activity By Targeting Plasmacytoid Dendritic Cells: Implications for a Novel Immune-Associated Mechanism

Arghya Ray, PhD, Deepika Sharma DAS, PhD, Yan Song, PhD, Vincent Macri, MA, Christopher L. Brooks, PhD, Eric K. Rowinsky, MD, Paul G. Richardson, MD, Dharminder Chauhan, PhD, Kenneth C Anderson, MD

Blood (2015) 126 (23): 3000.

https://doi.org/10.1182/blood.V126.23.3000.3000

Published: 2015

Journal Articles

The Hypoxia-Selective Epigenetic Agent, Rrx-001, Triggers Apoptosis and Overcomes Drug-Resistance in Multiple Myeloma Cells

Deepika Sharma Das, PhD, Arghya Ray, PhD, Yan Song, PhD, Paul Richardson, MD, Bryan Oronsky, Jan Scicinski, Dharminder Chauhan, PhD, Kenneth C Anderson, MD

Blood (2015) 126 (23): 918.

https://doi.org/10.1182/blood.V126.23.918.918

Published: 2015

Journal Articles

Targeting 19S-Proteasome Deubiquitinase Rpn11/POH1/PSMD14 in Multiple Myeloma

Yan Song, PhD, Arghya Ray, PhD, Deepika Sharma DAS, PhD, Dharminder Chauhan, PhD, Kenneth C Anderson, MD

Blood (2015) 126 (23): 1811.

https://doi.org/10.1182/blood.V126.23.1811.1811

Published: 2015

Journal Articles

Targeting Deubiquitylating Enzyme USP1 in Multiple Myeloma

Deepika Sharma Das, PhD, Yan Song, PhD, Arghya Ray, PhD, Paul Richardson, MD, Dharminder Chauhan, PhD, Kenneth C Anderson, MD

Blood (2015) 126 (23): 1813.

https://doi.org/10.1182/blood.V126.23.1813.1813

Published: 2015

Journal Articles

Combination of Anti-PD-L1 Antibody with IMiD® Immunomodulatory Drugs, HDAC Inhibitor ACY-1215, Bortezomib, or Toll-like Receptor 9 Agonist Enhances Anti-Tumor Immunity and Cytotoxicity in Multiple Myeloma

Arghya Ray, PhD, Deepika Sharma DAS, PhD, Yan Song, PhD, Dharminder Chauhan, PhD, Kenneth C Anderson, MD

Blood (2015) 126 (23): 3014.

https://doi.org/10.1182/blood.V126.23.3014.3014

Published: 2015

Journal Articles

Oral Proteasome Inhibitor Marizomib and IMiD® Imunomodulatory Drug Pomalidomide Trigger Synergistic Anti-Myeloma Activity and Enhanced Proteasome Inhibition in Vitro and In Vivo

Deepika Sharma Das, PhD, Arghya Ray, PhD, Yan Song, PhD, Paul Richardson, MD, Mohit Trikha, PhD, Dharminder Chauhan, PhD, Kenneth C Anderson, MD

Blood (2015) 126 (23): 1821.

https://doi.org/10.1182/blood.V126.23.1821.1821

Published: 2015

Journal Articles

A Novel Alkylating Agent Melphalan Flufenamide Ethyl Ester Induces an Irreversible DNA Damage in Multiple Myeloma Cells

Arghya Ray, PhD, Durgadevi Ravillah, PhD, Deepika Sharma Das, PhD, Yan Song, PhD, Eva Nordström, Jakob Lindberg, Paul G. Richardson, Dharminder Chauhan, PhD, Kenneth C. Anderson, MD

Blood (2014) 124 (21): 2086.

https://doi.org/10.1182/blood.V124.21.2086.2086

Published: 2014

Journal Articles

Synergistic Anti-Myeloma Activity of a Proteasome Inhibitor Marizomib and IMiD® Immunomodulatory Drug Pomalidomide

Deepika Sharma Das, PhD, Durgadevi Ravillah, PhD, Arghya Ray, Yan Song, PhD, Paul G. Richardson, Mohit Trikha, PhD, Dharminder Chauhan, PhD, Kenneth C. Anderson, MD

Blood (2014) 124 (21): 2099.

https://doi.org/10.1182/blood.V124.21.2099.2099

Published: 2014

Journal Articles

Targeting Proteasome Ubiquitin Receptor RPN13/ADRM1 in Multiple Myeloma

Yan Song, PhD, Deepika Sharma Das, PhD, Arghya Ray, PhD, Durgadevi Ravillah, PhD, Nikhil C. Munshi, MD, Dharminder Chauhan, PhD, Kenneth C. Anderson

Blood (2014) 124 (21): 419.

https://doi.org/10.1182/blood.V124.21.419.419

Published: 2014

Journal Articles

SL-401, a Novel Targeted Therapy Directed to the Interleukin-3 Receptor (IL-3R), Blocks Plasmacytoid Dendritic Cell (pDC)-Triggered Myeloma Cell Growth and Prevents Osteoclastogenesis

Arghya Ray, PhD, Deepika Sharma Das, PhD, Durgadevi Ravillah, PhD, Yan Song, PhD, Vincent Macri, Christopher Brooks, PhD, Eric Rowinsky, MD, Paul G. Richardson, Dharminder Chauhan, PhD, Kenneth C. Anderson, MD

Blood (2014) 124 (21): 3441.

https://doi.org/10.1182/blood.V124.21.3441.3441

Published: 2014

Journal Articles

Anti-Myeloma Activity of a Novel Glutaminase Inhibitor CB-839

Deepika Sharma Das, PhD, Durgadevi Ravillah, PhD, Arghya Ray, PhD, Yan Song, PhD, Nikhil C. Munshi, MD, Paul G. Richardson, Dharminder Chauhan, PhD, Kenneth C. Anderson, MD

Blood (2014) 124 (21): 3439.

https://doi.org/10.1182/blood.V124.21.3439.3439

Published: 2014

Journal Articles

Anti-Myeloma Activity of a Novel Free Radical Inducer Rrx-001

Deepika Sharma Das, PhD, Ze Tian, PhD, Arghya Ray, PhD, Durgadevi Ravillah, PhD, Yan Song, PhD, Paul G. Richardson, Bryan Oronsky, MD, Jan Scicinski, PhD, Dharminder Chauhan, PhD, Kenneth C. Anderson, MD

Blood (2014) 124 (21): 4712.

https://doi.org/10.1182/blood.V124.21.4712.4712

Published: 2014

NARROW

Combination of a Novel HDAC 6 Inhibitor ACY-241 with Anti-PD-L1 Antibody Enhances Anti-Tumor Immunity and Cytotoxicity in Multiple Myeloma

Deubiquitylating Enzyme USP1 As Therapeutic Target in Multiple Myeloma

SL-401, a Novel IL-3Rα/CD123-Directed Agent Targets Stem-like Cells in Multiple Myeloma

Deubiquitylating Enzyme Rpn11/POH1/PSMD14 As Therapeutic Target in Multiple Myeloma

A Novel Agent SL-401 Triggers Anti-Myeloma Activity By Targeting Plasmacytoid Dendritic Cells: Implications for a Novel Immune-Associated Mechanism

The Hypoxia-Selective Epigenetic Agent, Rrx-001, Triggers Apoptosis and Overcomes Drug-Resistance in Multiple Myeloma Cells

Targeting 19S-Proteasome Deubiquitinase Rpn11/POH1/PSMD14 in Multiple Myeloma

Targeting Deubiquitylating Enzyme USP1 in Multiple Myeloma

Combination of Anti-PD-L1 Antibody with IMiD® Immunomodulatory Drugs, HDAC Inhibitor ACY-1215, Bortezomib, or Toll-like Receptor 9 Agonist Enhances Anti-Tumor Immunity and Cytotoxicity in Multiple Myeloma

Oral Proteasome Inhibitor Marizomib and IMiD® Imunomodulatory Drug Pomalidomide Trigger Synergistic Anti-Myeloma Activity and Enhanced Proteasome Inhibition in Vitro and In Vivo

A Novel Alkylating Agent Melphalan Flufenamide Ethyl Ester Induces an Irreversible DNA Damage in Multiple Myeloma Cells

Synergistic Anti-Myeloma Activity of a Proteasome Inhibitor Marizomib and IMiD® Immunomodulatory Drug Pomalidomide

Targeting Proteasome Ubiquitin Receptor RPN13/ADRM1 in Multiple Myeloma

SL-401, a Novel Targeted Therapy Directed to the Interleukin-3 Receptor (IL-3R), Blocks Plasmacytoid Dendritic Cell (pDC)-Triggered Myeloma Cell Growth and Prevents Osteoclastogenesis

Anti-Myeloma Activity of a Novel Glutaminase Inhibitor CB-839

Anti-Myeloma Activity of a Novel Free Radical Inducer Rrx-001

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only